Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
HC-Tecartus (Brexucabtagene Autoleucel)Adults per Ther Dose (OTHER PX-025005608) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 29, 2026 , from http://ppman.hank.ai/transparency/procedure/PX-025005608/by-state?code_type=OTHER
“HC-Tecartus (Brexucabtagene Autoleucel)Adults per Ther Dose (OTHER PX-025005608) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/PX-025005608/by-state?code_type=OTHER. Accessed
June 29, 2026 .
“HC-Tecartus (Brexucabtagene Autoleucel)Adults per Ther Dose (OTHER PX-025005608) by State,” HANK Price Transparency ,
accessed June 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/PX-025005608/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
PX-025005608 — Hc-tecartus (Brexucabtagene Autoleucel)Adults Per Ther Dose
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,859,900
National median
$1,299,140 – $1,992,750
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for PX-025005608 (OTHER), with interquartile range
State Median p25 p75
MI $1,859,900 $1,299,140 $1,992,750